Practical Insights on Key Data From ESMO 2020 Informing Precision Medicine in NSCLC
CCO Oncology Podcast - A podcast by Clinical Care Options
Categories:
In this pocast episode, listen to Helena A. Yu, MD, a medical oncologist, and Maria E. Arcila, MD, a molecular pathologist, discuss new data on actionable mutations and targeted therapies in NSCLC from ESMO 2020, including emerging therapeutic strategies targeting EGFR or KRAS G12C driver mutations.
